UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 13.360

Sortiert nach

Analysis of tandem solar cell efficiencies under AM1.5G spectrum using a rapid flux calculation method

Progress in photovoltaics, 2008-05, Vol.16 (3), p.225-233

2008

Volltextzugriff (PDF)

Randomized multicenter phase II study of flavopiridol (alvocidib), cytarabine, and mitoxantrone (FLAM) versus cytarabine/daunorubicin (7+3) in newly diagnosed acute myeloid leukemia

Haematologica (Roma), 2015-09, Vol.100 (9), p.1172

2015

Volltextzugriff (PDF)

Submicron Emulsions as Colloidal Drug Carriers for Intravenous Administration: Comprehensive Physicochemical Characterization

Journal of pharmaceutical sciences, 1993-11, Vol.82 (11), p.1069-1079

1993

Volltextzugriff (PDF)

Characterization of plasmid DNA transfer into mouse skeletal muscle: evaluation of uptake mechanism, expression and secretion of gene products into blood

Gene therapy, 1996-03, Vol.3 (3), p.201

1996

Volltextzugriff (PDF)

Salvage transplantation for allograft failure using fludarabine and alemtuzumab as conditioning regimen

Bone marrow transplantation (Basingstoke), 2009-03, Vol.43 (6), p.477-480

2009

Volltextzugriff (PDF)

SAFETY AND EFFICACY OF CD37‐TARGETING NARATUXIMAB EMTANSINE PLUS RITUXIMAB IN DIFFUSE LARGE B‐CELL LYMPHOMA AND OTHER NON‐HODGKIN’S B‐CELL LYMPHOMAS – A PHASE 2 STUDY

Hematological oncology, 2021-06, Vol.39 (S2)

2021

Volltextzugriff (PDF)

PRELIMINARY RESULTS OF THE PHASE 2 STUDY OF ZANUBRUTINIB IN PATIENTS WITH PREVIOUSLY TREATED B‐CELL MALIGNANCIES INTOLERANT TO IBRUTINIB AND/OR ACALABRUTINIB

Hematological oncology, 2021-06, Vol.39 (S2)

2021

Volltextzugriff (PDF)

A new in vitro technique for the evaluation of drug release profile from colloidal carriers - ultrafiltration technique at low pressure

International journal of pharmaceutics, 1993-06, Vol.94 (1), p.115-123

1993

Volltextzugriff (PDF)

P524: PHASE 1B/2 STUDY ON SAFETY, PK, PD, AND PRELIMINARY EFFICACY OF THE SELECTIVE SYK INHIBITOR LANRAPLENIB IN COMBINATION WITH THE FLT3 INHIBITOR GILTERITINIB, IN FLT3‐MUTATED R/R AML (KB‐LANRA 1001)

HemaSphere, 2022-06, Vol.6, p.423-424

2022

Volltextzugriff (PDF)

PB1890: ZANUBRUTINIB IN ACALABRUTINIB‐INTOLERANT PATIENTS (PTS) WITH B‐CELL MALIGNANCIES

HemaSphere, 2022-06, Vol.6 (Suppl), p.1769-1770

2022

Volltextzugriff (PDF)

Nanostructured Absorbers for Multiple Transition Solar Cells

IEEE transactions on electron devices, 2008-03, Vol.55 (3), p.706-711

2008

Volltextzugriff (PDF)

PB2012: A PHASE 2 MULTIARM STUDY OF MAGROLIMAB COMBINATIONS IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA

HemaSphere, 2022-06, Vol.6 (Suppl), p.1883-1884

2022

Volltextzugriff (PDF)

P700: TREATMENT‐FREE REMISSION (TFR) AFTER DASATINIB IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML‐CP) AND DEEP MOLECULAR RESPONSE (DMR): FINAL 5‐YEAR RESULTS OF DASFREE

HemaSphere, 2022-06, Vol.6, p.595-596

2022

Volltextzugriff (PDF)

PB1828: CADENZA: A PIVOTAL STUDY OF PIVEKIMAB SUNIRINE (IMGN632) IN PATIENTS WITH UNTREATED/FRONTLINE BPDCN

HemaSphere, 2022-06, Vol.6 (Suppl), p.1708-1709

2022

Volltextzugriff (PDF)

Intratracheal gene delivery to the mouse airway: characterization of plasmid DNA expression and pharmacokinetics

Gene therapy, 1995-09, Vol.2 (7), p.450

1995

Volltextzugriff (PDF)

Characterization of diazepam submicron emulsion interface: Role of oleic acid

Journal of microencapsulation, 1994, Vol.11 (1), p.79-92

1994

Volltextzugriff (PDF)

EFFICACY AND SAFETY OF ELRANATAMAB (PF-06863135), A B-CELL MATURATION ANTIGEN (BCMA)-CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA

Hematology, Transfusion and Cell Therapy, 2021-10, Vol.43, p.S195-S196

2021

Volltextzugriff (PDF)

Optoelectronic evaluation of the nanostructuring approach to chalcopyrite-based intermediate band materials

Solar energy materials and solar cells, 2010-11, Vol.94 (11), p.1912-1918

2010

Volltextzugriff (PDF)

Active enhancer and chromatin accessibility landscapes chart the regulatory network of primary multiple myeloma

Blood, 2018-05, Vol.131 (19), p.2138-2150

2018

Volltextzugriff (PDF)

Efficacy evaluation of a novel submicron miconazole emulsion in a murine cryptococcosis model

Pharmaceutical research, 1995-02, Vol.12 (2), p.223-230

1995

Volltextzugriff (PDF)

Side-effect evaluation of a new diazepam formulation: venous sequela reduction following intravenous (iv) injection of a diazepam emulsion in rabbits

Pharmaceutical research, 1989-06, Vol.6 (6), p.510-516

1989

Volltextzugriff (PDF)

Design and characterization of a submicronized o/w emulsion of diazepam for parenteral use

International journal of pharmaceutics, 1989-09, Vol.54 (2), p.103-112

1989

Volltextzugriff (PDF)

NUMBER-NEEDED-TO-TREAT (NNT) AND COST OF RESPONSES ACHIEVED IN TYROSINE KINASE INHIBITOR (TKI) TREATMENT OF REFRACTORY CHRONIC-PHASE CHRONIC MYELOID LEUKEMIA (CP-CML) IN THE UNITED STATES (US)

Value in health, 2017-05, Vol.20 (5), p.A219

2017

Volltextzugriff (PDF)

Optoelectronic evaluation of the nanostructuring approach to chalcopyrite-based intermediate band materials: Inorganic and Nanostructured Photovoltaics (EMRS B)

Solar energy materials and solar cells, 2010, Vol.94 (11), p.1912-1918

2010

Volltextzugriff (PDF)

Efficacy evaluation of a novel submicron amphotericin B emulsion in murine candidiasis

Journal of medical and veterinary mycology, 1993, Vol.31 (3), p.207-218

1993

Volltextzugriff (PDF)

1 – 25 von 13.360

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(7.449)
Mit Volltextzugriff
(10.336)

Publikationsform

7 weitere anzeigen...

Weniger anzeigen...

Sprache

6 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB Electronic Journals Library
(5.008)
IngentaConnect
(3.384)
MEDLINE
(3.359)
JSTOR
(2.937)
Access via ScienceDirect (Elsevier)
(2.671)
Publisher or Other Site
(1.638)
Journals@Ovid Full Text
(1.178)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(990)
IngentaConnect Journals
(957)
SpringerLink (Online service)
(493)
EBSCOhost Business Source Ultimate
(465)
Wiley-Blackwell Journals
(462)
IEEE Xplore
(443)
Wiley Online Library
(295)
APS: American Physical Society E-Journals (Physics)
(248)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(237)
Oxford Journals
(232)
eBooks on EBSCOhost
(213)
PROLA
(213)
Ebook Central Perpetual and DDA
(170)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Analysis of tandem solar cell efficiencies under AM1.5G spectrum using a rapid flux calculation method

Randomized multicenter phase II study of flavopiridol (alvocidib), cytarabine, and mitoxantrone (FLAM) versus cytarabine/daunorubicin (7+3) in newly diagnosed acute myeloid leukemia

Submicron Emulsions as Colloidal Drug Carriers for Intravenous Administration: Comprehensive Physicochemical Characterization

Characterization of plasmid DNA transfer into mouse skeletal muscle: evaluation of uptake mechanism, expression and secretion of gene products into blood

Salvage transplantation for allograft failure using fludarabine and alemtuzumab as conditioning regimen

SAFETY AND EFFICACY OF CD37‐TARGETING NARATUXIMAB EMTANSINE PLUS RITUXIMAB IN DIFFUSE LARGE B‐CELL LYMPHOMA AND OTHER NON‐HODGKIN’S B‐CELL LYMPHOMAS – A PHASE 2 STUDY

PRELIMINARY RESULTS OF THE PHASE 2 STUDY OF ZANUBRUTINIB IN PATIENTS WITH PREVIOUSLY TREATED B‐CELL MALIGNANCIES INTOLERANT TO IBRUTINIB AND/OR ACALABRUTINIB

A new in vitro technique for the evaluation of drug release profile from colloidal carriers - ultrafiltration technique at low pressure

P524: PHASE 1B/2 STUDY ON SAFETY, PK, PD, AND PRELIMINARY EFFICACY OF THE SELECTIVE SYK INHIBITOR LANRAPLENIB IN COMBINATION WITH THE FLT3 INHIBITOR GILTERITINIB, IN FLT3‐MUTATED R/R AML (KB‐LANRA 1001)

PB1890: ZANUBRUTINIB IN ACALABRUTINIB‐INTOLERANT PATIENTS (PTS) WITH B‐CELL MALIGNANCIES

Nanostructured Absorbers for Multiple Transition Solar Cells

PB2012: A PHASE 2 MULTIARM STUDY OF MAGROLIMAB COMBINATIONS IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA

P700: TREATMENT‐FREE REMISSION (TFR) AFTER DASATINIB IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML‐CP) AND DEEP MOLECULAR RESPONSE (DMR): FINAL 5‐YEAR RESULTS OF DASFREE

PB1828: CADENZA: A PIVOTAL STUDY OF PIVEKIMAB SUNIRINE (IMGN632) IN PATIENTS WITH UNTREATED/FRONTLINE BPDCN

Intratracheal gene delivery to the mouse airway: characterization of plasmid DNA expression and pharmacokinetics

Characterization of diazepam submicron emulsion interface: Role of oleic acid

EFFICACY AND SAFETY OF ELRANATAMAB (PF-06863135), A B-CELL MATURATION ANTIGEN (BCMA)-CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA

Optoelectronic evaluation of the nanostructuring approach to chalcopyrite-based intermediate band materials

Active enhancer and chromatin accessibility landscapes chart the regulatory network of primary multiple myeloma

Efficacy evaluation of a novel submicron miconazole emulsion in a murine cryptococcosis model

Side-effect evaluation of a new diazepam formulation: venous sequela reduction following intravenous (iv) injection of a diazepam emulsion in rabbits

Design and characterization of a submicronized o/w emulsion of diazepam for parenteral use

NUMBER-NEEDED-TO-TREAT (NNT) AND COST OF RESPONSES ACHIEVED IN TYROSINE KINASE INHIBITOR (TKI) TREATMENT OF REFRACTORY CHRONIC-PHASE CHRONIC MYELOID LEUKEMIA (CP-CML) IN THE UNITED STATES (US)

Optoelectronic evaluation of the nanostructuring approach to chalcopyrite-based intermediate band materials: Inorganic and Nanostructured Photovoltaics (EMRS B)

Efficacy evaluation of a novel submicron amphotericin B emulsion in murine candidiasis

Suchergebnisse filtern